Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J N Fox

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
The British Journal of Radiology|December 1, 1994
Dynamic contrast-enhanced and fat suppressed magnetic resonance imaging in suspected recurrent carcinoma of the breast: preliminary experienceR W Kerslake, J N Fox, P J Carleton, et al.
Annals of Surgery|November 24, 1999
Prospective comparison of standard triple assessment and dynamic magnetic resonance imaging of the breast for the evaluation of symptomatic breast lesionsP J Drew, L W Turnbull, S Chatterjee, et al.
Annals of Surgical Oncology|September 24, 1999
Dynamic contrast enhanced magnetic resonance imaging of the breast is superior to triple assessment for the pre-operative detection of multifocal breast cancerP J Drew, S Chatterjee, L W Turnbull, et al.
British Journal of Cancer|November 20, 1998
Vascular endothelial growth factor in premenopausal women--indicator of the best time for breast cancer surgery?K Heer, H Kumar, V Speirs, et al.
British Journal of Cancer|December 4, 1998
Short-term primary culture of epithelial cells derived from human breast tumoursV Speirs, A R Green, D S Walton, et al.
Clinical Radiology|July 1, 1995
Dynamic gradient-echo and fat-suppressed spin-echo contrast-enhanced MRI of the breastR W Kerslake, P J Carleton, J N Fox, et al.
Cancer Research|September 18, 2001
Comparison of the short-term biological effects of 7alpha-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)-nonyl]estra-1,3,5, (10)-triene-3,17beta-diol (Faslodex) versus tamoxifen in postmenopausal women with primary breast cancerJ F Robertson, R I Nicholson, N J Bundred, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
The British Journal of Radiology|December 1, 1994
Dynamic contrast-enhanced and fat suppressed magnetic resonance imaging in suspected recurrent carcinoma of the breast: preliminary experienceR W Kerslake, J N Fox, P J Carleton, et al.
Annals of Surgery|November 24, 1999
Prospective comparison of standard triple assessment and dynamic magnetic resonance imaging of the breast for the evaluation of symptomatic breast lesionsP J Drew, L W Turnbull, S Chatterjee, et al.
Annals of Surgical Oncology|September 24, 1999
Dynamic contrast enhanced magnetic resonance imaging of the breast is superior to triple assessment for the pre-operative detection of multifocal breast cancerP J Drew, S Chatterjee, L W Turnbull, et al.
British Journal of Cancer|November 20, 1998
Vascular endothelial growth factor in premenopausal women--indicator of the best time for breast cancer surgery?K Heer, H Kumar, V Speirs, et al.
British Journal of Cancer|December 4, 1998
Short-term primary culture of epithelial cells derived from human breast tumoursV Speirs, A R Green, D S Walton, et al.
Clinical Radiology|July 1, 1995
Dynamic gradient-echo and fat-suppressed spin-echo contrast-enhanced MRI of the breastR W Kerslake, P J Carleton, J N Fox, et al.
Cancer Research|September 18, 2001
Comparison of the short-term biological effects of 7alpha-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)-nonyl]estra-1,3,5, (10)-triene-3,17beta-diol (Faslodex) versus tamoxifen in postmenopausal women with primary breast cancerJ F Robertson, R I Nicholson, N J Bundred, et al.
Pageof 4